Abstract:AIM To investigate whether inhibition of fibrosis in early stage can prevent diabetic nephropathy in rats. METHODS Seventy-two Sprague-Dawley(SD) rats were randomly divided into 3 groups: normal control, diabetic and diabetic rats treated with IFNγ subcutaneously(100 kU·kg~(-1)·d~(-1)) for 8 weeks. Diabetic model was made by a single intraperitoneal injection of streptozocin in a dose of 70 mg·kg~(-1). Six rats from each group were sacrificed at the end of week 1, 2, 4, 8, respectively. At each time-point, serum glucose, kidney hypertrophy index, urinary albumin excretion were detected. α Smooth muscle actin(αSMA) and collagen Ⅳ expression were studied by immunohistochemistry. The content of αSMA in renal cortex was also detected by enzyme-linked immunosorbent assay. RESULTS(At the end of) week 1, 2, 4 and 8, the content of α SMA in renal cortex of IFNγ group decreased (36.9%), 44.4%, 60.4% and 40.6%, respectively (as compared) with diabetic group(P0.05, n=5,6). Kidney hypertrophy index and collagen Ⅳ expression in IFNγ group were all higher than those of normal control rats, as well as diabetic rats. CONCLUSION Although IFNγ inhibits the expression of αSMA, it can′t prevent diabetic nephropathy.

Relationship Between Expression of Α Smooth Muscle Actin and Diabetic Nephropathy in Rats